Current Neuro-Oncology

Volume 22 Number 12
30 June 2020

Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 12, 30 June

Crotty EE, Leary SES, Geyer JR, Olson JM, Millard NE, Sato AA, Ermoian RP, Cole BL, Lockwood CM, Paulson VA, Browd SR, Ellenbogen RG, Hauptman JS, Lee A, Ojemann JG, Vitanza NA.
Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
J Neurooncol. 2020 Jun 16, 2020;148(3):607-617∟. doi: 10.1007/s11060-020-03558-w∟. PMID: 32556862∟. Observational study. ˍ

Delgado-Fernández J, Frade-Porto N, Blasco G, González-Tarno P, Gil-Simoes R, Li ZQ, Rivas PP, de Sola RG.
Does reintervention improve survival in recurrent glioblastoma? Facing a temporal bias in the literature.
Acta Neurochir (Wien). 2020 Jun 16. 2020;162(8):1967-1975∟. doi: 10.1007/s00701-020-04432-4∟. PMID: 32556522∟. Observational study. ˍ

Roetzer T, Furtner J, Gesperger J, Seebrecht L, Bandke D, Brada M, Brandner-Kokalj T, Grams A, Haybaeck J, Kitzwoegerer M, Leber SL, Marhold F, Moser P, Sherif C, Trenkler J, Unterluggauer J, Weis S, Wuertz F, Hainfellner JA, Langs G, Nenning KH, Woehrer A.
Sex-Specific Differences in Primary CNS Lymphoma.
Cancers (Basel). 2020 Jun 16, 2020;12(6):E1593∟. doi: 10.3390/cancers12061593∟. PMID: 32560244∟. Observational study. ˍ

Chen LH, Pan C, Diplas BH, Xu C, Hansen LJ, Wu Y, Chen X, Geng Y, Sun T, Sun Y, Zhang P, Wu Z, Zhang J, Li D, Zhang Y, Wu W, Wang Y, Li G, Yang J, Wang X, Xu C, Wang S, Waitkus MS, He Y, McLendon RE, Ashley DM, Yan H, Zhang L.
The integrated genomic and epigenomic landscape of brainstem glioma.
Nat Commun. 2020 Jun 17, 2020;11(1):3077∟. doi: 10.1038/s41467-020-16682-y∟. PMID: 32555164∟ Laboratory investigation. ˍ

D'alessandris QG, Martini M, Cenci T, Di Bonaventura R, Lauretti L, Stumpo V, Olivi A, Larocca LM, Pallini R, Montano N.
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach.
J Neurosurg Sci. 2020 Jun 17∟. doi: 10.23736/S0390-5616.20.04943-7∟. PMID: 32550606∟. Observational study˰ ˍ

Kumar A, Ballal S, Yadav MP, ArunRaj ST, Haresh KP, Gupta S, Damle NA, Garg A, Tripathi M, Bal C.
177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme: Proof of Concept.
Clin Nucl Med. 2020 Jun 17, 2020;45(12):e512-e513∟. doi: 10.1097/RLU.0000000000003142∟. PMID: 32558721∟. Case report. ˍ

Wu T, Qu PR, Zhang S, Li SW, Zhang J, Wang B, Liu P, Li CD, Zhao F.
The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a Retrospective analysis of 15 cases.
Sci Rep. 2020 Jun 17, 2020;10(1):9769∟. doi: 10.1038/s41598-020-66585-7∟. PMID: 32555264∟. Observational study. ˍ

Li Y, Nonaka M, Kanemura Y, Kodama Y, Mano M, Asai A.
A case of medulloblastoma in a patient with fetal ventricular enlargement.
Childs Nerv Syst. 2020 Jun 18, 2021;37(3):977-982∟. doi: 10.1007/s00381-020-04725-0∟. PMID: 32556458∟. Case report. ˍ

Winter SF, Vaios EJ, Muzikansky A, Martinez-Lage M, Bussière MR, Shih HA, Loeffler J, Karschnia P, Loebel F, Vajkoczy P, Dietrich J.
Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.
Oncologist. 2020 Jun 18, 2020;25(8):e1221-e1232∟. doi: 10.1634/theoncologist.2020-0085∟. PMID: 32488924∟ Observational study. ˍ

Khan I, Hatiboglu MA.
Can COVID-19 induce glioma tumorogenesis through binding cell receptors?
Med Hypotheses. 2020 Jun 19, 2020;144:110009∟. doi: 10.1016/j.mehy.2020.110009∟. PMID: 32758869∟. Laboratory investigation. ˍ

Marinari E, Allard M, Gustave R, Widmer V, Philippin G, Merkler D, Tsantoulis P, Dutoit V, Dietrich PY.
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma.
Oncoimmunology. 2020 Jun 21, 2020;9(1):1779990∟. doi: 10.1080/2162402X.2020.1779990∟. PMID: 32923142∟. Laboratory investigation. ˍ

Massimino M, Sunyach MP, Barretta F, Gandola L, Garegnani A, Pecori E, Spreafico F, Bonneville-Levard A, Meyronet D, Mottolese C, Boschetti L, Biassoni V, Schiavello E, Giussani C, Carrabba G, Diletto B, Pallotti F, Stefini R, Ferrari A, Terenziani M, Casanova M, Luksch R, Meazza C, Podda M, Chiaravalli S, Puma N, Bergamaschi L, Morosi C, Calareso G, Giangaspero F, Antonelli M, Buttarelli FR, Frappaz D.
Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
J Neurooncol. 2020 Jun 21, 2020;148(3):619-628∟. doi: 10.1007/s11060-020-03564-y∟. PMID: 32567042∟. Observational study. ˍ

Sedano P, Segundo CG, De Ingunza L, Cuesta-Álvaro P, Pérez-Somarriba M, Diaz-Gutiérrez F, Colino CG, Lassaletta A.
Real-world data for pediatric medulloblastoma: can we improve outcomes?
Eur J Pediatr. 2020 Jun 21, 2021;180(1):127-136∟. doi: 10.1007/s00431-020-03722-4∟. PMID: 32564147∟. Observational study. ˍ

García-Romero N, Palacín-Aliana I, Madurga R, Carrión-Navarro J, Esteban-Rubio S, Jiménez B, Collazo A, Pérez-Rodríguez F, Ortiz de Mendivil A, Fernández-Carballal C, García-Duque S, Diamantopoulos-Fernández J, Belda-Iniesta C, Prat-Acín R, Sánchez-Gómez P, Calvo E, Ayuso-Sacido A.
Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.
BMC Med. 2020 Jun 22, 2020;18(1):142∟. doi: 10.1186/s12916-020-01610-0∟. PMID: 32564774∟. Laboratory investigation. ˍ

Chen X, Fan Z, Li KK, Wu G, Yang Z, Gao X, Liu Y, Wu H, Chen H, Tang Q, Chen L, Wang Y, Mao Y, Ng HK, Shi Z, Yu J, Zhou L.
Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study.
Neurooncol Adv. 2020 Jun 22, 2020;2(1):vdaa079∟. doi: 10.1093/noajnl/vdaa079∟. PMID: 32760911∟. Observational study. ˍ

Almahariq F, Raguž M, Dlaka D, Marčinković P, Kaštelančić A, Orešković D, Chudy D.
Glioblastoma Multiforme developed in site of Motor Cortex Stimulation.
Neurochirurgie. 2020 Jun 23, 2020;66(4):284-286∟. doi: 10.1016/j.neuchi.2020.05.004∟. PMID: 32589902∟. Case report. ˍ

Nobre L, Zapotocky M, Khan S, Fukuoka K, Fonseca A, McKeown T, Sumerauer D, Vicha A, Grajkowska WA, Trubicka J, Li KKW, Ng HK, Massimi L, Lee JY, Kim SK, Zelcer S, Vasiljevic A, Faure-Conter C, Hauser P, Lach B, van Veelen-Vincent ML, French PJ, Van Meir EG, Weiss WA, Gupta N, Pollack IF, Hamilton RL, Nageswara Rao AA, Giannini C, Rubin JB, Moore AS, Chambless LB, Vibhakar R, Ra YS, Massimino M, McLendon RE, Wheeler H, Zollo M, Ferruci V, Kumabe T, Faria CC, Sterba J, Jung S, López-Aguilar E, Mora J, Carlotti CG, Olson JM, Leary S, Cain J, Krskova L, Zamecnik J, Hawkins CE, Tabori U, Huang A, Bartels U, Northcott PA, Taylor MD, Yip S, Hansford JR, Bouffet E, Ramaswamy V.
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.
Cell Rep Med. 2020 Jun 23, 2020;1(3):100038∟. doi: 10.1016/j.xcrm.2020.100038∟. PMID: 32743560∟. Observational study. ˍ

Zhao Z, Shen J, Zhang L, Wang L, Xu H, Han Y, Jia J, Lu Y, Yu R, Liu H.
Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation.
Biomater Sci. 2020 Jun 23, 2020;8(19):5306-5316∟. doi: 10.1039/d0bm00338g∟. PMID: 32573615∟. Laboratory investigation. ˍ

Kandels D, Pietsch T, Bison B, Warmuth-Metz M, Thomale UW, Kortmann RD, Timmermann B, Driever PH, Witt O, Schmidt R, Gnekow AK.
Loss of efficacy of subsequent non-surgical therapy after primary treatment failure in pediatric low-grade glioma patients - report from the German SIOP-LGG 2004 cohort.
Int J Cancer. 2020 Jun 24, 2020;147(12):3471-348∟. doi: 10.1002/ijc.33170∟. PMID: 32580249∟. Interventional study. ˍ

Rahman MA, Brekke J, Arnesen V, Hannisdal MH, Navarro AG, Waha A, Herfindal L, Rygh CB, Bratland E, Brandal P, Haasz J, Oltedal L, Miletic H, Lundervold A, Lie SA, Goplen D, Chekenya M.
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.
Immun Inflamm Dis. 2020 Jun 24, 2020;8(3):342-359∟. doi: 10.1002/iid3.315∟. PMID: 32578964∟ Interventional study. ˍ

Glavatskyi OY, Zemskova OV, Khmelnytskyi HV, Kardash KA, Shuba IM, Stuley VA.
Temozolomide in glioblastoma treatment: 15-year clinical experience and analysis of its efficacy.
Exp Oncol. 2020 Jun 25, 2020;42(2):148-156∟. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-2.14503∟. PMID: 32602292∟. Observational study. ˍ

Nagata A, Kanemasa Y, Kikuchi M, Otani R, Yamada R, Motoi T, Tamura T, Nakamura S, Funasaka C, Kageyama A, Shimoyama T, Shinoura N, Hishima T, Omuro Y.
Bone marrow metastasis of glioblastoma multiforme mimicking acute myeloid leukemia.
Oxf Med Case Reports. 2020 Jun 25, 2020;2020(6):omaa040∟. doi: 10.1093/omcr/omaa040∟. PMID: 32617167∟. Case report. ˍ

Li H, He Y, Huang L, Luo H, Zhu X.
The Nomogram Model Predicting Overall Survival and Guiding Clinical Decision in Patients With Glioblastoma Based on the SEER Database.
Front Oncol. 2020 Jun 26, 2020;10:1051∟. doi: 10.3389/fonc.2020.01051∟. PMID: 32676458∟. Observational study. ˍ

Kesherwani V, Shukla M, Coulter DW, Sharp JG, Joshi SS, Chaturvedi NK.
Long non-coding RNA profiling of pediatric Medulloblastoma.
BMC Med Genomics. 2020 Jun 26, 2020;13(1):87∟. doi: 10.1186/s12920-020-00744-7∟. PMID: 32591022∟. Laboratory investigation. ˍ

Seifert M, Schackert G, Temme A, Schröck E, Deutsch A, Klink B.
Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs.
Cancers (Basel). 2020 Jun 26, 2020;12(6):1696∟. doi: 10.3390/cancers12061696∟. PMID: 32604718∟. Laboratory investigation. ˍ

Cameron JM, Rinaldi C, Butler HJ, Hegarty MG, Brennan PM, Jenkinson MD, Syed K, Ashton KM, Dawson TP, Palmer DS, Baker MJ.
Stratifying Brain Tumour Histological Sub-Types: The Application of ATR-FTIR Serum Spectroscopy in Secondary Care.
Cancers (Basel). 2020 Jun 27, 2020;12(7):1710∟. doi: 10.3390/cancers12071710∟. PMID: 32605100∟. Observational study. ˍ

Cheng L, Yao Q, Ma L, Duan W, Guan J, Zhang C, Wang K, Liu Z, Jian F, Wu H, Chen Z, Wang X, Wang Z.
Predictors of mortality in patients with primary spinal cord glioblastoma.
Eur Spine J. 2020 Jun 27, 2020;29(12):3203-3213∟. doi: 10.1007/s00586-020-06515-3∟. PMID: 32594232∟. Observational study. ˍ

Choi SW, Cho HH, Koo H, Cho KR, Nenning KH, Langs G, Furtner J, Baumann B, Woehrer A, Cho HJ, Sa JK, Kong DS, Seol HJ, Lee JI, Nam DH, Park H.
Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance.
Cancers (Basel). 2020 Jun 27, 2020;12(7):1707∟. doi: 10.3390/cancers12071707∟. PMID: 32605068∟. Observational study. ˍ

Glazar DJ, Grass GD, Arrington JA, Forsyth PA, Raghunand N, Yu HM, Sahebjam S, Enderling H.
Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma.
J Clin Med. 2020 Jun 27, 2020;9(7):E2019∟. doi: 10.3390/jcm9072019∟. PMID: 32605050∟. Observational study. ˍ

Gatson NTN, Bross SP, Odia Y, Mongelluzzo GJ, Hu Y, Lockard L, Manikowski JJ, Mahadevan A, Kazmi SAJ, Lacroix M, Conger AR, Vadakara J, Nayak L, Chi TL, Mehta MP, Puduvalli VK.
Early imaging marker of progressing glioblastoma: a window of opportunity.
J Neurooncol. 2020 Jun 29, 2020;148(3):629-640∟. doi: 10.1007/s11060-020-03565-x∟. PMID: 32602020∟. Observational study. ˍ

Lee C, Ahn S, Park JS, Song JH, Hong YK, Jeun SS.
Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma.
Brain Tumor Res Treat. 2020 Jun 29, 2020;8(2):71-76∟. doi: 10.14791/btrt.2020.8.e12∟. PMID: 32648384∟. Observational study. ˍ

Alharbi M, Mobark NA, Balbaid AAO, Alanazi FA, Aljabarat WAR, Bakhsh EA, Ramkissoon SH, Abedalthagafi M.
Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib.
JCO Precis Oncol. 2020 Jun 30, 2020;4:PO.20.00017∟. doi: 10.1200/PO.20.00017∟. PMID: 32923892∟. Case report. ˍ

Lee JW, Lim DH, Sung KW, Cho HW, Ju HY, Hyun JK, Yoo KH, Koo HH, Suh YL, Joung YS, Shin HJ.
Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
Cancer Med. 2020 Jun 30, 2020;9(16):5807-5818∟. doi: 10.1002/cam4.3199∟. PMID: 32608158∟. Observational study. ˍ

Salehi A, Paturu MR, Patel B, Cain MD, Mahlokozera T, Yang AB, Lin TH, Leuthardt EC, Yano H, Song SK, Klein RS, Schmidt R, Kim AH.
Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy.
Neurooncol Adv. 2020 Jun 30, 2020;2(1):vdaa071∟. doi: 10.1093/noajnl/vdaa071∟. PMID: 32666049∟. Laboratory investigation. ˍ